AI: Face recognition and AI ethics

This is another longform that merits your attention. I have included summary below the blurb. We’re now having much the same conversation about AI in general (or more properly machine learning) and especially about face recognition, which has only become practical because of machine learning. And, we’re worrying about the same things - we worry … Continue reading AI: Face recognition and AI ethics

Knowledge Instrument: The Nooscope Manifested

This link is ONLY for the philosophical buffs. I did try to wrap my head around it but I have enclosed a quick summary below. The Nooscope is a cartography of the limits of artificial intelligence, intended as a provocation to both computer science and the humanities. Any map is a partial perspective, a way … Continue reading Knowledge Instrument: The Nooscope Manifested

AI for healthcare: How to Build Artificial Intelligence We Can Trust

These are interesting "computer science" problems and the authors have advanced their philosophical arguments as well- in effect to make the computers "aware". I think it is a monumental waste of time. An awareness of causality wouldn't offer any practical advantages unless they want a better "self-driving vehicle". In particular, we need to stop building … Continue reading AI for healthcare: How to Build Artificial Intelligence We Can Trust

AI hype: The Artificial “Intelligence” Scam is Imploding

The linked article is worth your time and read. There's nothing intelligent about "artificial intelligence" which is used as a catch-all term for machine learning. As the hype cycles have gone from boom to bust, what worries me is an AI "winter" wherein a good progress of technology would grind itself to a halt. If … Continue reading AI hype: The Artificial “Intelligence” Scam is Imploding

In the Face of a Pandemic, Can Pharma Shift Gears?

    I have been mentioning earlier- the prices are "obscene" only because of perverted incentives. It is foolhardy to expect them to invest in diseases which are not of immediate concern and governments don't see any "returns on investment". Diabetes and Insulin (or conversely "biologicals") will see higher rates of return for companies because … Continue reading In the Face of a Pandemic, Can Pharma Shift Gears?